Albumins: all 76 studies that test it

Page 1 of 1. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.

• Comparative Evaluation of Alb PRF Versus Connective Tissue Graft in Reconstruction of Deficient Interdental PapillaNot yet recruitingNCT07597135Phase 3
• "Effect of Albumin Combined With Furosemide in Critically Ill Patients With Fluid Overload: Impact on Urine Output and Renal Function"RecruitingNCT07417969Not applicable
• Modulation of Cerebral Ischemia by AlbuminRecruitingNCT07415655Phase 2
• Albumin in Acute Variceal BleedingNot yet recruitingNCT07395141Phase 3
• Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2RecruitingNCT07263308Phase 3
• A Clinical Comparison of Connective Tissue Graft and Alb-PRF for Rebuilding Interdental PapillaNot yet recruitingNCT07139392Phase 3
• Comparison of Safety and Efficacy of Tailored Versus Fixed Dose Albumin for the Management of Patients With Cirrhosis and Sepsis Associated Acute Kidney InjuryNot yet recruitingNCT06809088Not applicable
• The Intensive Care Platform TrialRecruitingNCT06667999Phase 4
• Study on the Role of Human Serum Albumin in Large Acute Ischemic Stroke of Anterior Circulation After ThrombectomyRecruitingNCT06629116Not applicable
• Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.Not yet recruitingNCT06245590Not applicable
• Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced HypotensionNot yet recruitingNCT06076330Not applicable
• High Dose Albumin in Refractory AscitesRecruitingNCT05867602Phase 2
• Fluid Challenge and Plasma Volume, During SurgeryRecruitingNCT05726136Phase 4
• Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral SclerosisCompletedNCT02479802Phase 2Results posted
• Furosemide and Albumin for Diuresis of Edema: A Pilot Randomized Controlled TrialCompletedNCT02055872Phase 3Results posted
• A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's DiseaseCompletedNCT01561053Phase 2/3Results posted
• Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric PatientsTerminatedNCT01531803Phase 4Results posted
• Albumin for Intracerebral Hemorrhage InterventionTerminatedNCT00990509Phase 2Results posted
• Albumin in Acute Ischemic Stroke TrialTerminatedNCT00235495Phase 3Results posted
• Albumin and Furosemide for Preventing Ovarian Hyperstimulation Syndrome in ICSI PatientsCompletedNCT07568886Not applicable
• Transthoracic Echocardiographic Monitoring of Cardiac Output Effects of Colloid Preload and Crystalloid Coload During Cesarean Delivery Under Spinal AnesthesiaCompletedNCT06654687Not applicable
• Comparison of Fluid Resuscitation in Pediatric Burn Patients Using Crystalloids and With Albumin on Day Two.CompletedNCT06224777Phase 2/3
• Initial Resuscitation With Albumin in Hemorrhagic Shock to Reduce Positive Fluid BalanceStatus unknownNCT06111261Not applicable
• Midodrine Plus Albumin Versus Midodrine Alone to Prevent Cirrhosis Related Complications in Children With Cirrhosis and AscitesCompletedNCT06091345Not applicable
• Hepatic Encephalopathy and Albumin Lasting Cognitive ImprovementActive, not recruitingNCT06052176Phase 2
• Intra-arterial Albumin Infusion After Endovascular Therapy for Stroke PatientsCompletedNCT05953623Phase 1
• Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D).CompletedNCT05937048Not applicable
• 20% Albumin vs. Balanced Salt Solution as Resuscitation Fluid in Cirrhosis With Sepsis Induced HypotensionStatus unknownNCT05441878Phase 4
• Comparison Between Hyperoncotic and Isooncotic Albumin to Support Blood Loss ReplacementCompletedNCT05391607Phase 4
• Microcirculation Recruitment Using Albumin 20% and Terlipressin in Septic PatientsStatus unknownNCT05080543Phase 1
• Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.Status unknownNCT04679571Not applicable
• Midodrine and Albumin in Patients With Refractory AscitesStatus unknownNCT04621617Phase 3
• Fluid Mobilization in Hospitalized Patients With Acute Kidney InjuryCompletedNCT04522635Phase 4
• To Study Efficacy of Albumin in Cirrhosis With Spontaneous Bacterial Peritonitis at Low Risk for AKI DevelopmentStatus unknownNCT04437810Not applicable
• Plasma Exchange With Albumin in AMN PatientsCompletedNCT04303416Phase 2/3
• Low Dose Albumin Versus Standard Dose Albumin in High Risk Spontaneous Bacterial Peritonitis.CompletedNCT04273373Not applicable
• Resuscitation With Albumin 5% in Dengue Haemorrhagic FeverStatus unknownNCT04076254Phase 3
• Albumin for Hepatocellular CarcinomaStatus unknownNCT03974074Phase 3
• Impact of Hyperoncotic Albumin to Support Blood Loss ReplacementCompletedNCT03848507Phase 4
• Efficacy of Albumin Therapy With Standard Medical Treatment (SMT) as Compared to Standard Medical Treatment (SMT) in Improving Patient Survival and Immune Modulation in Patients With Acute on Chronic Liver Failure (ASIA Trial).Status unknownNCT03754400Not applicable
• The Effect of Balanced Crystalloid Versus 5% Albumin on Endothelial Glycocalyx Degradation in Patients Undergoing Off-pump Coronary Artery Bypass SurgeryCompletedNCT03699462Phase 4
• ALBumin Italian Outcome Septic Shock-BALANCED Trial (ALBIOSS-BALANCED)CompletedNCT03654001Phase 3
• HEAL STUDY (Hepatic Encephalopathy and Albumin Study)CompletedNCT03585257Phase 2
• Infusion Rate and Volume Kinetics for Hyperoncotic Albumine in Healthy SubjectsCompletedNCT03453320Phase 4
• A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTSWithdrawnNCT03365414Phase 3
• Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic PatientStatus unknownNCT03153306Phase 4
• Volume Kinetics for Hyperoncotic Albumin in Burn Patients as Well as for Healthy SubjectsCompletedNCT02952378Phase 4
• Effects of Fluid Balance Control in Critically Ill PatientsCompletedNCT02765009Not applicable
• Comparison of Standard Dose Versus Once a Day Intravenous Albumin in Spontaneous Bacterial PeritonitisCompletedNCT02756741Not applicable
• Albumin vs. Plasma for PEdiAtric pRiming TrialCompletedNCT02738190Phase 4
• Comparison of Colloid (20% Albumin) Versus Crystalloid (Plasmalyte) for Fluid Resuscitation in Cirrhotics With Sepsis Induced Hypotension.CompletedNCT02721238Not applicable
• Effect of Albumin Administration on Vasopressor Duration in Resolving Septic ShockTerminatedNCT02716597Phase 1
• To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver FailureCompletedNCT02573727Not applicable
• Albumin in Cardiac SurgeryCompletedNCT02560519Phase 4
• Volume Kinetics for 20% Albumin in Different Clinical SituationsStatus unknownNCT02556580Phase 4
• Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.CompletedNCT02467348Not applicable
• To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.CompletedNCT02467322Not applicable
• Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced HypotensionCompletedNCT02462902Not applicable
• The INFECIR-2 Albumin Prevention StudyTerminatedNCT02034279Phase 4
• Treatment of Type-1 Hepatorenal Syndrome Associated With SepsisCompletedNCT01932151Not applicable
• Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment FailureCompletedNCT01852630Not applicable
• Impact of Fluid Resuscitation Therapy on Pulmonary Edema as Measured by Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome (ARDS)Status unknownNCT01763853Phase 4
• Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal FailureWithdrawnNCT01587222Phase 2
• Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic EncephalopathyCompletedNCT01559519Phase 4
• Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic ResponseStatus unknownNCT01530711Phase 4
• Lactated Ringer Versus Albumin in Early Sepsis TherapyCompletedNCT01337934Phase 3
• Effect of Hyperoncotic Albumin on Vascular Hemodynamics and Oxygen Delivery Following Orthotopic Liver TransplantStatus unknownNCT01328132Phase 4
• Midodrine and Albumin for Cirrhotic Patients With Functional Renal ImpairmentCompletedNCT01133795Phase 2
• Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.CompletedNCT00968695Phase 4
• Efficacy of Albumin for Acute Encephalopathy in Patients With CirrhosisCompletedNCT00886925Phase 4
• Low-dose Albumin Solution in SBP: a Randomized Double-blind Pilot StudyStatus unknownNCT00852800Phase 2
• Post-Operative Use of Salt Poor Albumin Solution in Resuscitation of Orthotopic Liver TransplantStatus unknownNCT00842803Not applicable
• Fluid Resuscitation in Early Septic ShockCompletedNCT00819416Phase 2
• Early Albumin Resuscitation During Septic ShockCompletedNCT00327704Phase 4
• The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney DysfunctionCompletedNCT00240045Phase 2/3
• Formation and Severity of Pressure Ulcers Associated With 4% Albumin vs. 0.9% Sodium ChlorideCompletedNCT00228657Phase 1/2

← Albumins overview